Novaminsulfon



Indications and Reactions:

Role Indications Reactions
Primary
Gastric Bypass 33.3%
Analgesic Therapy 11.1%
Autoimmune Thyroiditis 11.1%
Chronic Spontaneous Urticaria 11.1%
Product Used For Unknown Indication 11.1%
Prophylaxis Against Gastrointestinal Ulcer 11.1%
Urticaria 11.1%
Agranulocytosis 50.0%
Anaphylactic Reaction 50.0%
Secondary
Pain 13.1%
Hypertension 12.1%
Sedation 8.4%
Prophylaxis 7.9%
Rash 7.4%
Anaesthesia 6.7%
Product Used For Unknown Indication 5.7%
Parenteral Nutrition 4.9%
Infection 4.2%
Electrolyte Substitution Therapy 3.7%
Fluid Replacement 3.7%
Constipation 3.2%
Drug Use For Unknown Indication 3.0%
Mechanical Ventilation 3.0%
Thrombosis Prophylaxis 3.0%
Hypovolaemia 2.5%
Oedema 2.5%
Infection Prophylaxis 2.0%
Mineral Supplementation 1.7%
Arthralgia 1.5%
Toxic Epidermal Necrolysis 25.6%
Agranulocytosis 11.6%
Hypotension 9.3%
Stevens-johnson Syndrome 9.3%
Osteoarthritis 7.0%
Dyspnoea 4.7%
Syncope 4.7%
Autoimmune Thrombocytopenia 2.3%
Dermatitis Allergic 2.3%
Hepatitis 2.3%
Hepatitis Acute 2.3%
Herpes Zoster 2.3%
Neutropenia 2.3%
Overdose 2.3%
Pancytopenia 2.3%
Pyrexia 2.3%
Restlessness 2.3%
Tachycardia 2.3%
Vomiting 2.3%
Concomitant
Product Used For Unknown Indication 20.9%
Drug Use For Unknown Indication 18.0%
Pain 10.3%
Hypertension 9.0%
Rheumatoid Arthritis 7.3%
Prophylaxis 4.3%
Osteoporosis 3.6%
Parkinson's Disease 3.3%
Hiv Infection 3.0%
Non-small Cell Lung Cancer 2.7%
Hypothyroidism 2.5%
Coronary Artery Disease 2.4%
Nausea 2.0%
Analgesic Therapy 1.7%
Back Pain 1.5%
Breast Cancer 1.5%
Non-small Cell Lung Cancer Stage Iv 1.5%
Chest Pain 1.5%
Headache 1.5%
Type 2 Diabetes Mellitus 1.5%
Sepsis 11.5%
Vomiting 10.1%
Weight Decreased 10.1%
Somnolence 9.1%
Pneumonia 6.3%
Syncope 6.3%
General Physical Health Deterioration 4.8%
Nausea 4.8%
Delirium 4.3%
Pulmonary Embolism 3.8%
Thrombocytopenia 3.8%
Pyrexia 3.4%
Cytokine Release Syndrome 2.9%
Faecaloma 2.9%
Pain 2.9%
Transaminases Increased 2.9%
Urinary Retention 2.9%
Colitis 2.4%
Pleural Effusion 2.4%
Ruptured Cerebral Aneurysm 2.4%